期刊簡介 | |||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Vaccines LetPub Score 7.3
51 ratings
Rate
Reputation 8.2 Influence 6.0 Speed 9.6 | ||||||||||||||||||||||||||||||||
期刊簡稱 | VACCINES-BASEL | ||||||||||||||||||||||||||||||||
ISSN | 2076-393X | ||||||||||||||||||||||||||||||||
h-index | N.A. | ||||||||||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||||||||||
自引率 (2023-2024) | 17.30%自引率趨勢 | ||||||||||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||||||||||
官方網站 | https://www.mdpi.com/journal/vaccines | ||||||||||||||||||||||||||||||||
在線稿件提交 | https://login.mdpi.com/login?_target_path=https%3A%2F%2Fsusy.mdpi.com%2Fuser%2Flogin%3FauthAll%3Dtrue | ||||||||||||||||||||||||||||||||
開放訪問 | Yes | ||||||||||||||||||||||||||||||||
出版商 | MDPI (Basel, Switzerland) | ||||||||||||||||||||||||||||||||
主題領域 | Pharmacology, Toxicology and Pharmaceutics | ||||||||||||||||||||||||||||||||
出版國/地區 | Switzerland | ||||||||||||||||||||||||||||||||
發行頻率 | |||||||||||||||||||||||||||||||||
創刊年 | 2013 | ||||||||||||||||||||||||||||||||
每年文章數 | 1803每年文章數趨勢 | ||||||||||||||||||||||||||||||||
黃金OA百分比 | 99.61% | ||||||||||||||||||||||||||||||||
OA Related Info | APC: Yes( CHF2700; ) APC waiver:Check Notes Other charges: No Keywords: immunopathogenesis、vaccines Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | ||||||||||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2076-393X%5BISSN%5D | ||||||||||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 18.06 Day(s) 來自作者的數據: 11 Weeks | ||||||||||||||||||||||||||||||||
競爭力 * | 來自作者的數據: | ||||||||||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
首頁 上一頁 1 下一頁 末頁 (頁 | |
[Vaccines] 的評論 | 撰寫評論 |
作者: 德云小生 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-06-15 22:16:12 評論於 I did not submit the manuscript. Because the comment cannot be submitted without filling in the above information, I randomly filled in one with an unknown result already submitted! It's not necessary to spend 20,000 to submit to a Q3 journal from MDPI! The reputation is too bad! To be honest, it is not recommended to submit to Q2, unless you are in a hurry to publish and conclude the article! I receive almost every month invitation to submit manuscripts to several Q2/Q3 journals under their umbrella(0) 讚! | 德云小生 |
作者: KK 領域: 生物学 審稿時間: 1.0 month(s) 結果: 修改後接受 撰寫評論 |
2024-03-12 10:52:24 評論於 Received Date 7 February 2024 Revised Date 6 March 2024 Accepted Date 7 March 2024 Published Date 9 March 2024(0) 讚! | KK |
作者: jivin 領域: 医学 審稿時間: 1.0 month(s) 結果: 修改後接受 撰寫評論 |
2023-08-09 08:24:47 評論於 MDPI is particularly simple, easy to use, and fast (under normal circumstances). This year, its highest impact factor (IF) is Vaccines, which is suitable for beginners to practice with (under no special requirements).(0) 讚! | jivin |
作者: 橙皮漫步 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-15 19:44:45 評論於 It's already March 15th, but it's still pending review. It's really agonizing.(0) 讚! | 橙皮漫步 |
作者: 橙皮漫步 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-15 19:44:03 評論於 2023.3.11 Submission Pending review(0) 讚! | 橙皮漫步 |
作者: DSK 領域: 審稿時間: 0.0 month(s) 結果: 拒稿 撰寫評論 |
2022-12-19 12:28:06 評論於 The fast reviewing process of this journal was satisfying for me. I have published 2 papers in this journal. The evaluation processes were uncomplicated for both of the documents. The editors are also supportive.(0) 讚! | DSK |
作者: youzi 領域: 生物 審稿時間: 1.0 month(s) 結果: 修改後接受 撰寫評論 |
2020-03-08 18:45:02 評論於 There were 4 reviewers in total, and the review was detailed, and the questions were very core. The suggestions were helpful to the article. The result of the first review was returned in about 2 weeks, and the result of the second review was replied in about 4 days. Submission is indeed a learning process! Come on! (5) 讚! | youzi |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us